InnoPharmax Inc.

InnoPharmax, founded in 2005 in Taipei, Taiwan, is a specialty pharmaceutical company that transforms existing injectables into effective oral dosage forms through its OralPAS® self-microemulsifying drug delivery system. Also develops OralPAS Pro® and MUCR platforms, focusing on oncology, immunology, and infectious diseases. Ranked 7th fastest growing tech company in Taiwan by Deloitte Technology Fast 500 Asia-Pacific.